Glycoprotein Ibα inhibitor (CCP-224) prevents neutrophil-platelet aggregation in Sickle Cell Disease

Blood Adv. 2017 Sep 12;1(20):1712-1716. doi: 10.1182/bloodadvances.2017006742.

Maritza A Jimenez^{1

2}, Enrico Novelli^{1

3}, Gray D Shaw⁴, Prithu Sundd^{1

2

5}

¹ Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
² Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
³ Division of Hematology and Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
⁴ Quell Pharma Inc., Half Moon Bay, CA, USA.
⁵ Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Abstract